PUBLICATIONS · 30110579
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2018 Aug 23
- First author
- Litton JK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2018 Nov;15(11):655. doi: 10.1038/s41571-018-0090-3.
- note
- Source null
- related pmid
- 30177682
- relationship
- Comment in
Authors and identifiers
- name
- Litton JK
- type
- Author
- name
- Rugo HS
- type
- Author
- name
- Ettl J
- type
- Author
- name
- Hurvitz SA
- type
- Author
- name
- Gonçalves A
- type
- Author
- name
- Lee KH
- type
- Author
- name
- Fehrenbacher L
- type
- Author
- name
- Yerushalmi R
- type
- Author
- name
- Mina LA
- type
- Author
- name
- Martin M
- type
- Author
- name
- Roché H
- type
- Author
- name
- Im YH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Litton JK
- type
- Author
- name
- Rugo HS
- type
- Author
- name
- Ettl J
- type
- Author
- name
- Hurvitz SA
- type
- Author
- name
- Gonçalves A
- type
- Author
- name
- Lee KH
- type
- Author
- name
- Fehrenbacher L
- type
- Author
- name
- Yerushalmi R
- type
- Author
- name
- Mina LA
- type
- Author
- name
- Martin M
- type
- Author
- name
- Roché H
- type
- Author
- name
- Im YH
- type
- Author
- bibliography ids
- nci-bib-8c885253f19eb3f8d939e950
- book metadata
- content sha256
- 9a5e284500fcdf8c8c36e680d3f8c8db20e67e286331bbb7aed979e35132e6e8
- document type
- citation
- dois
- 10.1056/NEJMoa1802905
- electronic publication date
- display
- 2018 Aug 15
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30110579
- immutable id
- pubmed:30110579@9a5e284500fcdf8c8c36e680d3f8c8db20e67e286331bbb7aed979e35132e6e8
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 8
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 753-763
- volume
- 379
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2018 Nov;15(11):655. doi: 10.1038/s41571-018-0090-3.
- note
- Source null
- related pmid
- 30177682
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 30110579
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- 7f766600b301f00293504d20588c5a203bc7a7b457b581596173760a64decbcf
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Aug 23
- precision
- day
- year
- 2018
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Preserved source evidence · Not medical advice
Triangle